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This paper describes a report of one patient with con-
junctival melanoma widely spreaded on the bulbar, tarsal 
conjunctiva and connection of the tarsal conjunctiva and 
eyelid skin. A discussion of the diagnostic and therapeutic 
considerations will follow.
Case report
A 69-year-old female patient was referred to our hospi-
tal with a pigmented lesion widely spreaded on the bulbar, 
tarsal conjunctiva and connection of the tarsal conjunc-
tiva and eyelid skin of the right eye. The small pigmented 
lesion was reported 10 years ago after she has suffered a 
shot to the eye. In that time it was small, ﬂ at lesion next 
to the limbus. In her medical record it was reported as 
conjunctival melanosis. She was re-examinated two more 
times in next 6 months. She did not refer to an ophthal-
mologist for many years, despite the recommended control 
examinations at least once a year.
In December 2011 full ophthalmologic examination 
was performed and revealed nodular, large pigmented 
conjuntival lesion with increased vascularization and 
spreading on palpebral skin (Figures 1–3). There was no 
pigmented lesion on the left eye, but she had a record of 
Primary acquired melanosis (PAM) is an uncommon, 
almost always unilateral condition. It is characterized by 
proliferation of conjunctival epithelial melanocytes and it 
is not just deposition of pigment. The signs of PAM are 
irregular, unifocal or multifocal areas of ﬂ at brown pig-
mentation which may involve any part of the conjunctiva1. 
Primary acquired melanosis (PAM) is an acquired pig-
mentation of the conjunctival epithelium, a preinvasive 
pigmented lesion2. The other melanocytic lesions of the 
ocular adnexa include nevi and malignant melanoma2.
PAM can be with or without atypia. PAM with atypia 
is a pre-malignanat condition. Most types of acquired 
melanosis remain benign, but if PAM is associated with 
cellular atypia, it can progress to conjunctival melanoma, 
according to some studies in up to 46% cases3. Malignant 
transformation should be suspected when a lesion shows 
nodularity, enlargement, or increased vascularity.
All suspicious lesions should be histological exami-
nated. Small areas of PAM can be observed and biopsy 
delayed unless they progress. However, pigmented lesions 
located on the palpebral or forniceal conjunctiva, plica or 
caruncule should increase clinical suspicion and lead to 
biopsy3. Although conjunctival melanoma has rare preva-
lence, it is potentially lethal ocular tumor.
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A B S T R A C T
Primary acquired melanosis (PAM) is an acquired pigmentation of the conjunctival epithelium, a preinvasive pig-
mented lesion. When it is associated with cellular atypia it can lead to the developement of melanoma. We report a case 
report of malignant melanoma of the conjuntiva, which arrised from the conjuntival PAM. The disease was too extensive 
for ocular conservation, therefore exenteration was performed. This case highlights the need for regular follow-up of pa-
tients with melanocytic lesions of the ocular adnexa, and particular attention to the surgical technique, and careful follow-
up to detect further disease activity.
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occlusion of the central retinal artery and cataract forma-
tion. Visual acuity on the right eye with correction was 
0.7, and on the left eye was 0.3. Her affected eye was the 
eye with better visual acuity.
Conjuntival biopsy showed a tumor tissue composed of 
a cluster of atypical melanocytes whose nuclei contain 
prominent nucleoli compatible with malignant melanoma 
of the conjunctiva (Figures 4–7).
Ultrasound of the both eyes was within normal ﬁ nd-
ings because the tumor was in front and was not available 
to the ultrasound analysis.
Magnetic resonance imaging (MRI) revealed no 
spreading to the orbita.
Before therapeutic decision, MSCT (brain, orbital, ab-
domen, thorax, sacrum) was performed for melanoma 
staging. There was no evidence of metastatic disease.
Fig. 1. Conjuntival malignant melanoma of the right eye on ﬁ rst 
presentation with extension into the cornea,bulbar, forniceal and 
palpebral conjunctiva.
Fig. 4. Conjunctival clip, partially ulcerated; tumor tissue com-
posed of atypical melanocytes, some of which contain melanin 
pigment.
Fig. 5. Under conjunctiva and into the conjunctiva observes the 
melanoma tumor tissue.
Fig. 6. Melanoma tumor inﬁ ltrating subepithelial cornea, and 
stratiﬁ ed epithelium of the stroma (40x).
Fig. 7. Melanoma tumor inﬁ ltrating subepithelial cornea, and 
stratiﬁ ed epithelium of the stroma (200x).
Fig. 2. Raised pigmented, nodular limbal lesion.
Fig. 3. Extension of the malignant melanoma into the cornea.
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On skeletal scintigraphy (Tc-99m MDP) there was no 
evidence of the pathologic accumulation.
As the oncologist said that with primary irradiation it 
is not possible to achieve a longer control of the disease, 
the only therapeutic approach was radical surgery.
The disease was too extensive for ocular conservation. 
With an informed written consent she was presented for 
surgery. Exenteration of the right orbit was performed. 
Postoperative recovery was uneventful. Psychiatrist was 
consulted and he recommended therapy.
A month later, she underwent a cataract surgery on the 
left eye with slightly better visual result. The patient has 
participated in regular follow up. PET-CT scan was per-
formed once a year. There were no further problems for 
more than two years to date.
We report a case of malignant melanoma of the con-
junctiva with local spreading on a bulbar, tarsal conjunc-
tiva and connection of the tarsal conjunctiva and eyelid 
skin. There was no evidence of distant metastasis.
Discussion
PAM of the conjunctiva has been the subject of contro-
versy in incidence, natural course and management4–7. 
PAM accounted for 11% of all conjunctival tumors and 21% 
of melanocytic lesions5. The best clinical approach is still 
a matter of debate.
Pigmented lesions of the conjunctiva may be melano-
cytic or non-melanocytic. Melanocytic lesions of the con-
junctiva can be classiﬁ ed into nevi, melanosis and malig-
nant melanoma8. Conjunctival nevus is the most common 
melanocytic lesion of the conjunctiva. They can vary in 
size and pigmentation. They are usually mobile over the 
surface of the globe9.
PAM of the conjunctiva is acquired, almost always uni-
lateral, brown or tan colored ﬂ at lesion of the conjunctiva. 
It affects mainly adults, with median age at referral 56 
years4. PAM is classiﬁ ed on the basis of histopathology 
into PAM without atypia and PAM with atypia.
It differs from a nevus historically as it is acquired in 
middle age, and clinically lacks a cystic component9.
Architectural abnormalities and cytological features 
are criteria for deﬁ ning atypia.
Discontinuous lentiginous spread of atypical malano-
cytes, extension above the basal layer of the epithelium 
with intraepithelial nesting, full thickness epithelial dis-
position and pagetoid ascent are the most important ar-
chitectural abnormalities. Cytological changes are nucle-
ar hyperchromasia and enlargement, epitheloid 
morphology. Also there should be immunohistochemical 
evidence of the melanocytic proliferation and increased 
cell proliferation9.
PAM with severe atypia shows progression to mela-
noma in 13%2.
Malignant melanomas of the conjunctiva are rare but 
potentially lethal. They are accounting for less than 2% of 
ocular malignancies9–11. Malignant melanoma of the con-
junctiva can arise from apparently normal conjunctiva, 
from PAM and from naevi12.
The tumor can spread through lymphatic and blood-
stream. It most commonly metastasizes to the lung, liver, 
brain and bone. Also it can directly extend to the globe 
and orbit13. Limbal location may carry greater risk of in-
traocular spread10.
While the management of PAM depends on the extent 
of involvement, the management of the conjunctival mela-
nomas includes surgical resection with a wide margin 
excision9,14.
PAM can be just observed, but in suspicious cases ex-
cisonal biopsy is mandatory.
Surgical resection of the malignant melanoma of the 
conjunctiva must be planed like wide surgical excision 
with a wide margin excision (more than 3 mm)13,14. Also
Cryotherapy may be included, topical mitomycin 
C(MMC) and/or alcohol epitheliectomy9, and topical inter-
feron alf-2b15. Also radiotherapy can be a method of choice 
in some cases, such as orbital recurrences.
As malignant melanoma can metastasize, it is very 
important to examine the patient’s regional lymph nodes, 
and consult the oncology service for a systemic metastatic 
workup9.
For the evaluation of cutaneous melanoma PET-CT has 
a large value. Sensitivity and speciﬁ city for detecting me-
tastasis are higher for PET than for any other conven-
tional imaging procedures16.
PAT –CT can detect lymph node metastasis and guide 
initial staging of patients with conjunctival melanoma17.
As the malignant melanoma of the conjunctiva is rare, 
there are some difﬁ culties with staging. For a correct di-
agnosis, decision of treatment procedure and patients 
follow-up is very important to have good multidisciplinary 
approach.
This case emphasizes the need for some important 
rules in case of pigmented conjunctival lesions:
 ● Regular observation of a small PAM lesions (<3 clock 
hours).
 ● Performing an excisinal biopsy for a larger lesion.
 ● All suspicious lesions should be histologicaly exami-
nated.
 ● Appropriate surgical resection of malignant melanoma 
of the conjunctiva and implementing the other thera-
peutic procedures if needed.
 ● Good examination of the patient for a possible metas-
tasis.
 ● Long follow-up of the patient with appropriate imaging 
procedures.
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PROGRESIJA PRIMARNE MELANOZE SPOJNICE U RASPROSTRANJENI MALIGNI MELANOM 
SPOJNICE
S A Ž E T A K
Primarna melanoza spojnice je stečena pigmentcija epitela spojnice, preinvazivna pigmentna lezija. Kada se razvije 
stanična atipija može nastati melanom. Prikazujemo slučaj malignog melanoma spojnice koji se razvio od primarne 
melanoze spojnice. Bolest je bila izrazito raspostranjena, oko se nije moglo sačuvati i u svrhu liječenja je učinjena egzen-
teracija orbite. Ovim prikazom slučaja želimo istaknuti važnost redovitih kontrola pigmentnih lezija spojnice i očnih 
adneksa. Iznimno je važno obratiti pozornost na planiranje kirurške tehnike te nastaviti praćenje aktivosti bolesti re-
dovitim kontrolama.
